tm
Seeing Is Believing
tm
Seeing Is Believing
TRVI is currently covered by 12 analysts with an average price target of $22.35. This is a potential upside of $9.41 (72.72%) from yesterday's end of day stock price of $12.94.
Trevi Therapeutics's activity chart (see below) currently has 88 price targets and 106 ratings on display. The stock rating distribution of TRVI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 56.48% with an average time for these price targets to be met of 481.21 days.
Highest price target for TRVI is $31, Lowest price target is $16, average price target is $22.35.
Most recent stock forecast was given by DEBANJANA CHATTERJEE from JONESTRADING on 14-Aug-2026. First documented stock forecast 03-Jun-2019.
Currently out of the existing stock ratings of TRVI, 30 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Mar-2026
$28
$16.12 (135.69%)
$24
2 months 9 days ago
(14-Aug-2026)
0/2 (0%)
$9.54 (51.68%)
Buy Since 24-May-2022
$25
$13.12 (110.44%)
$24
2 months 16 days ago
(07-Aug-2026)
2/6 (33.33%)
$6.49 (35.06%)
1235
Buy Since 01-Jul-2025
$30
$18.12 (152.53%)
$25
2 months 16 days ago
(07-Aug-2026)
0/3 (0%)
$11.49 (62.07%)
Buy Since 12-Apr-2023
$31
$19.12 (160.94%)
3 months 3 days ago
(20-Jul-2026)
3/6 (50%)
$14.23 (84.85%)
384
Buy Since 13-Jun-2024
$24
$12.12 (102.02%)
$21
3 months 3 days ago
(20-Jul-2026)
1/8 (12.5%)
$7.23 (43.11%)
358
What is TRVI (Trevi Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on TRVI (Trevi Therapeutics)?
Which analyst has the most public recommendations on TRVI (Trevi Therapeutics)?
Which analyst is the currently most bullish on TRVI (Trevi Therapeutics)?
Which analyst is the currently most reserved on TRVI (Trevi Therapeutics)?
